Does BELINOSTAT Cause Peripheral t-cell lymphoma unspecified recurrent? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Peripheral t-cell lymphoma unspecified recurrent have been filed in association with BELINOSTAT (Beleodaq). This represents 4.9% of all adverse event reports for BELINOSTAT.
15
Reports of Peripheral t-cell lymphoma unspecified recurrent with BELINOSTAT
4.9%
of all BELINOSTAT reports
0
Deaths
0
Hospitalizations
How Dangerous Is Peripheral t-cell lymphoma unspecified recurrent From BELINOSTAT?
Of the 15 reports.
Is Peripheral t-cell lymphoma unspecified recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELINOSTAT. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does BELINOSTAT Cause?
Disease progression (64)
Nausea (50)
Death (40)
Vomiting (36)
Dyspnoea (31)
Anaemia (29)
Fatigue (27)
Constipation (24)
Platelet count decreased (24)
White blood cell count decreased (21)
What Other Drugs Cause Peripheral t-cell lymphoma unspecified recurrent?
PRALATREXATE (11)
PREDNISONE (9)
BRENTUXIMAB VEDOTIN (8)
CYCLOPHOSPHAMIDE (8)
DOXORUBICIN (8)
ETOPOSIDE (7)
RUXOLITINIB (7)
METOPROLOL (5)
MIRTAZAPINE (5)
PANTOPRAZOLE (5)
Which BELINOSTAT Alternatives Have Lower Peripheral t-cell lymphoma unspecified recurrent Risk?
BELINOSTAT vs BELUMOSUDIL
BELINOSTAT vs BELVIQ
BELINOSTAT vs BELZUTIFAN
BELINOSTAT vs BEMPEDOIC ACID
BELINOSTAT vs BEMPEDOIC ACID\EZETIMIBE